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Background
In aggressive lymphoma, systemic “B” symptoms of
fatigue, fever, night sweats may occur frequently, but
these symptoms may occur also in severe sepsis. Many
hematological disorders, especially lymphoid neo-
plasms, have a high risk for infection because of altered
humoral and cell-mediated immunity.
Case report
We present a case of a man 37 years old who was diag-
nosed in our clinic on July 2014 with diffuse large B-cell
lymphoma. On July 5 the patient was admitted to the
County Hospital Piteşti with fatigue, fever, night sweats
and epigastric pain. Laboratory evaluation remarks a
severe pancytopenia but without inflammation marks
and a positive procalcitonin.
Marrow aspiration sample showed 28% lymphoid cells.
The patient was transferred in our clinic with the diagno-
sis of sepsis. From family history we remark that his
mother had died a few years back at 50 years old with
acute leukemia. After clinical exam (pallor, splenomegaly),
laboratory evaluation (severe pancytopenia: leukocytes
0.88x103/µL, neutrophils 0.49x103/µL, Hb 9.5 g/dL,
platelets 25x103/µL), LDH 1,704 IU/L, prothrombin time
16.5 s, fibrinogen 46 mg/dL, partial thromboplastin time
56.9 s, procalcitonin 3.95 ng/mL), abdominal CT scan, we
considered intra-abdominal sepsis and disseminated intra-
vascular coagulation (DIC).
Treatment for 7 days with meronem 3g/day, corticother-
apy and supportive therapy, fresh frozen plasma, packed
red blood cells, platelet concentrates did not ameliorate
the clinical status and surgery exam disproved our suspi-
cion. Because procalcitonin rose to 10.35 ng/mL treatment
was completed with vancomycin 2g/day, caspofungin
50 mg/day, levofloxacin 1g/day, amikacin 1g/day and
ethambutol 1g/day and also we performed a bone marrow
biopsy.
After 5 days procalcitonin was 1.57 ng/mL and the clini-
cal status was ameliorated but pancytopenia persisted. The
histopathological exam and the immunohistochemistry
aspect sustained the diagnosis of diffuse large B-cell lym-
phoma and the patient was transferred to the Hematology
Clinic.
Conclusion
In patients with severe infection who have a long evolution
we must search for a hematological disease. Sometimes
both hematological disease and sepsis may intertwine,
being difficult to make a plain distinction.
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